Monday, June 28, 2021

PharmEasy gets $300 million booster shot for Thyrocare deal

PharmEasy has raised $300 million more, bringing the total funding received by the online pharmacy since April to $650 million, most of which will be used to fund its ongoing acquisition of diagnostics chain Thyrocare.

from Tech-Economic Times https://ift.tt/3Afitz4
at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Schools reach out to Canvas hackers as breach hits US classrooms

A cybercriminal group, ShinyHunters, stole vast amounts of student data from the educational platform Canvas. Some affected schools and uni...